↓ Skip to main content

Cochrane Database of Systematic Reviews

Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus

Overview of attention for article published in Cochrane database of systematic reviews, May 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)

Citations

dimensions_citation
154 Dimensions

Readers on

mendeley
243 Mendeley
Title
Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
Published in
Cochrane database of systematic reviews, May 2013
DOI 10.1002/14651858.cd008107.pub2
Pubmed ID
Authors

Ulrich Ronellenfitsch, Matthias Schwarzbach, Ralf Hofheinz, Peter Kienle, Meinhard Kieser, Tracy E Slanger, Katrin Jensen, GE Adenocarcinoma Meta‐analysis Group

Abstract

The outcome of patients with locally advanced gastroesophageal adenocarcinoma (adenocarcinoma of the esophagus, gastroesophageal (GE) junction, and stomach) is poor. There is conflicting evidence regarding the effects of perioperative chemotherapy on survival and other outcomes.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 243 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 <1%
Unknown 242 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 28 12%
Student > Ph. D. Student 27 11%
Student > Bachelor 26 11%
Student > Postgraduate 22 9%
Other 20 8%
Other 63 26%
Unknown 57 23%
Readers by discipline Count As %
Medicine and Dentistry 131 54%
Nursing and Health Professions 13 5%
Biochemistry, Genetics and Molecular Biology 7 3%
Psychology 5 2%
Agricultural and Biological Sciences 4 2%
Other 14 6%
Unknown 69 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 October 2018.
All research outputs
#7,387,249
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#8,415
of 11,499 outputs
Outputs of similar age
#59,385
of 207,187 outputs
Outputs of similar age from Cochrane database of systematic reviews
#192
of 266 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 207,187 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 266 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.